Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€1.74
19.04.21
€3.00
19.04.22
7.47%
03.05.21

Could be worthwhile Investment >10% per year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.50
19.04.21
€15.00
19.04.22
29.41%
03.05.21

Could be worthwhile Investment >10% per year
buy
Inotiv Inc.

Start price
Target price
Perf. (%)
€17.38
19.04.21
€20.00
19.04.22
14.28%
03.05.21

Could be worthwhile Investment >10% per year
buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€3.10
19.04.21
€5.00
19.04.22
9.03%
03.05.21

Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€27.74
23.04.21
-
23.04.22
26.17%
03.05.21

Risky Investment
Heat Biologics Inc.

Start price
Target price
Perf. (%)
€12.11
08.08.20
-
04.11.21
-50.12%
27.04.21

Risky Investment
buy
LexaGene Holdings Inc.

Start price
Target price
Perf. (%)
€0.92
11.02.21
€2.00
11.02.22
-52.92%
20.04.21

buy
CytoTools AG

Start price
Target price
Perf. (%)
€10.20
12.08.20
€26.00
04.11.21
56.86%
13.04.21

Could be very worthwhile Investment >20% year
Differentiated customer and product portfolio
buy
Benitec Biopharma Inc.

Start price
Target price
Perf. (%)
€5.50
23.03.21
€8.00
23.03.22
-18.55%
03.04.21

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€12.90
17.10.20
-
04.11.21
-29.07%
24.03.21

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Risky balance sheet
buy
Heat Biologics Inc.

Start price
Target price
Perf. (%)
€11.10
09.02.21
-
09.02.22
-41.26%
07.03.21

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Some uniques
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.22
21.02.21
-
21.02.22
-5.21%
06.03.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Celsion Corp.

Start price
Target price
Perf. (%)
€35.70
22.02.21
€60.00
22.02.22
-37.40%
06.03.21

Could be worthwhile Investment >10% per year
Good culture
Leading role in innovation
high free float
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€32.25
08.02.21
€50.00
08.02.22
6.98%
22.02.21

Could be worthwhile Investment >10% per year
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.12
08.02.21
€5.00
08.02.22
14.10%
22.02.21

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€3.44
08.02.21
€5.00
08.02.22
-27.31%
22.02.21

Could be worthwhile Investment >10% per year
iBio Inc.

Start price
Target price
Perf. (%)
€54.00
15.08.20
€17.50
04.11.21
-22.69%
20.02.21

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€36.75
25.01.21
€50.00
25.01.22
-12.24%
08.02.21

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€2.10
25.01.21
€3.00
25.01.22
63.56%
08.02.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€22.25
11.01.21
€75.00
11.01.22
65.17%
25.01.21

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€0.79
11.01.21
€2.00
11.01.22
166.14%
25.01.21

Could be worthwhile Investment >10% per year
buy
Burcon Nutrascience Corp.

Start price
Target price
Perf. (%)
€2.81
10.01.21
-
10.01.22
7.84%
23.01.21

Risky Investment
Enzon Pharmaceuticals

Start price
Target price
Perf. (%)
€0.10
14.11.20
-
14.11.21
120.00%
14.01.21

Risky Investment
Nicheplayer
Higher risks for its business
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€13.00
14.12.20
€25.00
14.12.21
71.15%
11.01.21

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€0.72
14.12.20
€2.00
14.12.21
9.69%
11.01.21

Could be worthwhile Investment >10% per year